Although wound exudate is a necessary component of wound healing, it can delay healing of chronic wounds. Exudate management consists of reducing excess while maintaining a moist healing environment. The COVID-19 pandemic has complicated wound care by limiting access to outpatient services. Negative pressure wound therapy (NPWT) is ideal for exudate management during this pandemic because it decreases the need for in-person wound care and thus reduces potential exposure to COVID-19.

This clear and well-researched white paper discusses wound exudate in detail—what it is, what it does, how it affects patients’ quality of life, and how it can promote or impair healing. The guide provides strategies for managing exudate in the current COVID-19 pandemic. It ends with an overview of NPWT, an established, evidence-based advanced wound therapy for managing wound exudate.

Wound care professionals will appreciate this in-depth exploration of wound exudate and strategies to manage it, including NPWT for optimal outcomes in their patients with complex wounds.

This white paper covers the following topics:

Sponsored by Medela